Analyst Reco. GSK plc

Equities

Market Closed - London Stock Exchange Other stock markets 11:35:05 2023-11-28 am EST			5-day change	1st Jan Change
1,411.80 ^GBX	-0.17%		-0.40%	-1.79%

05:51pm	Pfizer disappointed in RSV shot's market share, CFO says	RE
09:50am	Novartis Touts R&D Pipeline Progress, Upgraded Midterm Targets as Pure-play Medicines Company	MT

GSK : Receives a Buy rating from Deutsche Bank	03:06am	ZD
Jefferies Reduces GSK PT, Maintains Hold Recommendation	Nov. 22	MT
GSK : Jefferies remains Neutral	Nov. 22	ZD
RBC cuts HSBC; Liberum cuts Glencore	Nov. 22	AN
GSK: JEFFERIES CUTS TARGET PRICE TO 1550P FROM 1650P…	Nov. 21	RE
GSK : Jefferies reiterates its Neutral rating	Nov. 16	ZD
Berenberg: GSK's RSV Vaccine Caution 'Understandable' as Prescription Growth Slows	Nov. 08	MT
GSK : Berenberg keeps its Buy rating	Nov. 08	ZD
Berenberg Lowers GSK PT, Maintains Buy Rating	Nov. 08	MT
Berenberg Bank Adjusts GSK Price Target to $41 From $44, Maintains Buy Rating	Nov. 08	MT
ANALYST RECOMMENDATIONS : AMD, Chevron, Ebay, Quanta Services, UPS...	Nov. 08
UBS downbeat on AJ Bell and Hargreaves Lansdown	Nov. 08	AN
GSK : Receives a Buy rating from Deutsche Bank	Nov. 02	ZD
JPMorgan Lifts GSK PT, Maintains Underweight Rating	Nov. 02	MT
Bank of America starts Unite Group with 'buy'	Nov. 02	AN
GSK : JP Morgan reiterates its Sell rating	Nov. 02	ZD
GSK PLC : Q3 exceeded expectations; outlook upgraded ‘again’	Nov. 01
GSK : Gets a Sell rating from UBS	Nov. 01	ZD
GSK : Jefferies gives a Neutral rating	Nov. 01	ZD
GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings -- Update	Nov. 01	DJ

No results for this search

GSK PLC : Q3 exceeded expectations; outlook upgraded ‘again’

November 01, 2023 at 11:02 am EDT